
Organogenesis Holdings Inc.
ORGOHealthcare|Drug Manufacturers - Specialty & Generic|US
$0.81
-0.03 (-3.18%)
DCF Value
$3.83
Tangible Book / Share
$1.79
Cash / Share
$0.17
Ownership Breakdown
47.9%
Float
128.7M
Shares Outstanding
61.6M
Float Shares
Major Holders (27)
Combined: 240.7%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Thompson Dean | Individual | 18.00% | 28,680,359 | Nov 19, 2024 | 13D/G |
| Alan A. Ades | IN, OO | 17.60% | 22,319,836 | Jun 26, 2025 | 13D/G |
| David Burgstahler | Individual | 17.60% | 28,057,746 | Nov 19, 2024 | 13D/G |
| Avista Capital Managing Member VI, LLC | Other | 16.70% | 26,502,042 | Nov 19, 2024 | 13D/G |
| Avista Capital Partners VI GP, L.P. | Partnership | 16.70% | 26,502,042 | Nov 19, 2024 | 13D/G |
| Albert Erani | IN, OO | 14.10% | 17,920,498 | Jun 26, 2025 | 13D/G |
| Avista Healthcare Partners III, L.P. | Partnership | 11.60% | 17,340,628 | Nov 19, 2024 | 13D/G |
| AHP III Orchestra Holdings, L.P. | Partnership | 11.30% | 16,945,025 | Nov 19, 2024 | 13D/G |
| Soleus GP LLC | Other | 9.90% | 12,484,876 | Feb 11, 2025 | 13D/G |
| Glenn H. Nussdorf | IN, OO | 9.70% | 12,248,560 | Nov 3, 2025 | 13D/G |
| Guy Levy | Individual | 7.90% | 9,985,951 | Feb 12, 2026 | 13D/G |
| Soleus Capital Management, L.P. | Partnership | 7.90% | 9,985,951 | Feb 12, 2026 | 13D/G |
| Soleus GP, LLC | Other | 7.90% | 9,985,951 | Feb 12, 2026 | 13D/G |
| Soleus Capital Master Fund, L.P. | Non-US institution | 7.90% | 9,985,951 | Feb 12, 2026 | 13D/G |
| Soleus Capital, LLC | Other | 7.90% | 9,985,951 | Feb 12, 2026 | 13D/G |
| Soleus Capital Group, LLC | Other | 7.90% | 9,985,951 | Feb 12, 2026 | 13D/G |
| Dennis Erani | IN, OO | 7.90% | 10,043,701 | Jun 26, 2025 | 13D/G |
| Dennis Erani 2012 Issue Trust dated 12/20/12 | Other | 6.60% | 8,382,031 | Jun 26, 2025 | 13D/G |
| Organo PFG LLC | Other | 6.50% | 8,279,490 | Jun 26, 2025 | 13D/G |
| Josette Ades | Individual | 6.40% | 8,112,497 | Jun 26, 2025 | 13D/G |
| GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 | Other | 6.20% | 7,928,570 | Nov 3, 2025 | 13D/G |
| RED Holdings, LLC | Other | 5.30% | 6,784,024 | Jun 26, 2025 | 13D/G |
| Mathew P. Arens | Individual | 3.06% | 3,888,816 | Feb 17, 2026 | 13D/G |
| First Light Asset Management, LLC | Investment adviser | 2.85% | 3,611,616 | Feb 17, 2026 | 13D/G |
| Alan Ades 2014 GRAT | Other | 2.40% | 3,075,865 | Jun 26, 2025 | 13D/G |
| Organo Investors LLC | Other | 2.20% | 2,851,984 | Jun 26, 2025 | 13D/G |
| GN 2016 Family Trust u/a/d August 12, 2016 | Other | 0.70% | 918,680 | Nov 3, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 4,705,452 acquired · 1,367,610 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Grow Brian | Chief Commercial Officer | Jan 10, 2025 | OPTION EX. | 958 | $1.24 | $1.2K | Form 4 |
| Grow Brian | Chief Commercial Officer | Jan 10, 2025 | OPTION EX. | 958 | $1.24 | $1.2K | Form 4 |
| Leibowitz Arthur S | director | Mar 9, 2026 | BUY | 5,000 | $2.68 | $13.4K | Form 4 |
| Driscoll Michael Joseph | director | Mar 9, 2026 | BUY | 10,000 | $2.67 | $26.7K | Form 4 |
| Cavorsi Robert | Vice President, Strategy | Mar 1, 2026 | TAX W/H | 700 | $3.21 | $2.2K | Form 4 |
| Montecalvo Antonio S. | Vice President, Health Policy | Feb 18, 2026 | AWARD | 11,330 | — | — | Form 4 |
| Montecalvo Antonio S. | Vice President, Health Policy | Feb 18, 2026 | TAX W/H | 3,778 | $3.84 | $14.5K | Form 4 |
| Gillheeney Gary S. | director, officer: President and CEO | Feb 18, 2026 | AWARD | 188,856 | — | — | Form 4 |
| Gillheeney Gary S. | director, officer: President and CEO | Feb 18, 2026 | TAX W/H | 91,311 | $3.84 | $350.6K | Form 4 |
| Grow Brian | Chief Commercial Officer | Feb 18, 2026 | AWARD | 48,818 | — | — | Form 4 |
| Grow Brian | Chief Commercial Officer | Feb 18, 2026 | TAX W/H | 11,887 | $3.84 | $45.6K | Form 4 |
| Bilbo Patrick | Chief Operating Officer | Feb 18, 2026 | AWARD | 49,102 | — | — | Form 4 |
| Bilbo Patrick | Chief Operating Officer | Feb 18, 2026 | TAX W/H | 16,375 | $3.84 | $62.9K | Form 4 |
| Francisco David | Chief Financial Officer | Feb 18, 2026 | AWARD | 44,040 | — | — | Form 4 |
| Francisco David | Chief Financial Officer | Feb 18, 2026 | TAX W/H | 14,687 | $3.84 | $56.4K | Form 4 |
| Cavorsi Robert | Vice President, Strategy | Feb 18, 2026 | AWARD | 16,454 | — | — | Form 4 |
| Cavorsi Robert | Vice President, Strategy | Feb 18, 2026 | TAX W/H | 5,487 | $3.84 | $21.1K | Form 4 |
| Freedman Lori | Chief Admin. and Legal Officer | Feb 18, 2026 | AWARD | 43,212 | — | — | Form 4 |
| Freedman Lori | Chief Admin. and Legal Officer | Feb 18, 2026 | TAX W/H | 14,411 | $3.84 | $55.3K | Form 4 |
| McGuire Patrick | Chief Accounting Officer | Feb 18, 2026 | OTHER | 0 | — | — | Form 4 |
| McGuire Patrick | Chief Accounting Officer | Feb 18, 2026 | OTHER | 0 | — | — | Form 4 |
| McGuire Patrick | Chief Accounting Officer | Feb 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Freedman Lori | Chief Admin. and Legal Officer | Feb 18, 2026 | AWARD | 42,780 | — | — | Form 4 |
| Freedman Lori | Chief Admin. and Legal Officer | Feb 18, 2026 | TAX W/H | 14,267 | $3.84 | $54.8K | Form 4 |
| Freedman Lori | Chief Admin. and Legal Officer | Feb 18, 2026 | AWARD | 203,125 | — | — | Form 4 |
| Freedman Lori | Chief Admin. and Legal Officer | Feb 18, 2026 | AWARD | 115,812 | $3.84 | $444.7K | Form 4 |
| Cavorsi Robert | Vice President, Strategy | Feb 18, 2026 | AWARD | 16,290 | — | — | Form 4 |
| Cavorsi Robert | Vice President, Strategy | Feb 18, 2026 | TAX W/H | 5,432 | $3.84 | $20.9K | Form 4 |
| Cavorsi Robert | Vice President, Strategy | Feb 18, 2026 | AWARD | 93,750 | — | — | Form 4 |
| Cavorsi Robert | Vice President, Strategy | Feb 18, 2026 | AWARD | 53,452 | $3.84 | $205.3K | Form 4 |
| Francisco David | Chief Financial Officer | Feb 18, 2026 | AWARD | 43,602 | — | — | Form 4 |
| Francisco David | Chief Financial Officer | Feb 18, 2026 | TAX W/H | 14,541 | $3.84 | $55.8K | Form 4 |
| Francisco David | Chief Financial Officer | Feb 18, 2026 | AWARD | 195,312 | — | — | Form 4 |
| Francisco David | Chief Financial Officer | Feb 18, 2026 | AWARD | 111,358 | $3.84 | $427.6K | Form 4 |
| Grow Brian | Chief Commercial Officer | Feb 18, 2026 | AWARD | 48,330 | — | — | Form 4 |
| Grow Brian | Chief Commercial Officer | Feb 18, 2026 | TAX W/H | 11,768 | $3.84 | $45.2K | Form 4 |
| Grow Brian | Chief Commercial Officer | Feb 18, 2026 | AWARD | 234,375 | — | — | Form 4 |
| Grow Brian | Chief Commercial Officer | Feb 18, 2026 | AWARD | 133,630 | $3.84 | $513.1K | Form 4 |
| Bilbo Patrick | Chief Operating Officer | Feb 18, 2026 | AWARD | 48,612 | — | — | Form 4 |
| Bilbo Patrick | Chief Operating Officer | Feb 18, 2026 | TAX W/H | 16,212 | $3.84 | $62.3K | Form 4 |
| Bilbo Patrick | Chief Operating Officer | Feb 18, 2026 | AWARD | 210,937 | — | — | Form 4 |
| Bilbo Patrick | Chief Operating Officer | Feb 18, 2026 | AWARD | 120,267 | $3.84 | $461.8K | Form 4 |
| Gillheeney Gary S. | director, officer: President and CEO | Feb 18, 2026 | AWARD | 186,968 | — | — | Form 4 |
| Gillheeney Gary S. | director, officer: President and CEO | Feb 18, 2026 | TAX W/H | 90,398 | $3.84 | $347.1K | Form 4 |
| Gillheeney Gary S. | director, officer: President and CEO | Feb 18, 2026 | AWARD | 890,625 | — | — | Form 4 |
| Gillheeney Gary S. | director, officer: President and CEO | Feb 18, 2026 | AWARD | 507,795 | $3.84 | $1.9M | Form 4 |
| Driscoll Michael Joseph | director | Feb 18, 2026 | AWARD | 48,828 | — | — | Form 4 |
| Giacomin Jon L | director | Feb 18, 2026 | AWARD | 48,828 | — | — | Form 4 |
| Leibowitz Arthur S | director | Feb 18, 2026 | AWARD | 48,828 | — | — | Form 4 |
| Montecalvo Antonio S. | Vice President, Health Policy | Feb 18, 2026 | AWARD | 11,218 | — | — | Form 4 |
| Montecalvo Antonio S. | Vice President, Health Policy | Feb 18, 2026 | TAX W/H | 3,741 | $3.84 | $14.4K | Form 4 |
| Montecalvo Antonio S. | Vice President, Health Policy | Feb 18, 2026 | AWARD | 40,625 | — | — | Form 4 |
| Montecalvo Antonio S. | Vice President, Health Policy | Feb 18, 2026 | AWARD | 23,162 | $3.84 | $88.9K | Form 4 |
| Quintero Gilberto | director | Feb 18, 2026 | AWARD | 48,828 | — | — | Form 4 |
| Duraibabu Prathyusha | director | Feb 18, 2026 | AWARD | 48,828 | — | — | Form 4 |
| Lustig Garrett | director | Feb 18, 2026 | AWARD | 48,828 | — | — | Form 4 |
| Korfin Michele Ilene | director | Feb 18, 2026 | AWARD | 48,828 | — | — | Form 4 |
| Francisco David | Chief Financial Officer | Feb 15, 2026 | TAX W/H | 3,898 | $3.73 | $14.5K | Form 4 |
| Francisco David | Chief Financial Officer | Feb 15, 2026 | TAX W/H | 21,412 | $3.73 | $79.9K | Form 4 |
| Francisco David | Chief Financial Officer | Feb 15, 2026 | TAX W/H | 13,369 | $3.73 | $49.9K | Form 4 |
| Francisco David | Chief Financial Officer | Feb 15, 2026 | TAX W/H | 13,769 | $3.73 | $51.4K | Form 4 |
| Bilbo Patrick | Chief Operating Officer | Feb 15, 2026 | TAX W/H | 5,114 | $3.73 | $19.1K | Form 4 |
| Bilbo Patrick | Chief Operating Officer | Feb 15, 2026 | TAX W/H | 28,331 | $3.73 | $105.7K | Form 4 |
| Bilbo Patrick | Chief Operating Officer | Feb 15, 2026 | TAX W/H | 15,617 | $3.73 | $58.3K | Form 4 |
| Bilbo Patrick | Chief Operating Officer | Feb 15, 2026 | TAX W/H | 15,352 | $3.73 | $57.3K | Form 4 |
| Cavorsi Robert | Vice President, Strategy | Feb 15, 2026 | TAX W/H | 6,667 | $3.73 | $24.9K | Form 4 |
| Cavorsi Robert | Vice President, Strategy | Feb 15, 2026 | TAX W/H | 5,549 | $3.73 | $20.7K | Form 4 |
| Cavorsi Robert | Vice President, Strategy | Feb 15, 2026 | TAX W/H | 5,442 | $3.73 | $20.3K | Form 4 |
| Freedman Lori | Chief Admin. and Legal Officer | Feb 15, 2026 | TAX W/H | 4,043 | $3.73 | $15.1K | Form 4 |
| Freedman Lori | Chief Admin. and Legal Officer | Feb 15, 2026 | TAX W/H | 24,428 | $3.73 | $91.1K | Form 4 |
| Freedman Lori | Chief Admin. and Legal Officer | Feb 15, 2026 | TAX W/H | 12,761 | $3.73 | $47.6K | Form 4 |
| Freedman Lori | Chief Admin. and Legal Officer | Feb 15, 2026 | TAX W/H | 13,510 | $3.73 | $50.4K | Form 4 |
| Gillheeney Gary S. | director, officer: President and CEO | Feb 15, 2026 | TAX W/H | 24,340 | $3.73 | $90.8K | Form 4 |
| Gillheeney Gary S. | director, officer: President and CEO | Feb 15, 2026 | TAX W/H | 78,646 | $3.73 | $293.3K | Form 4 |
| Gillheeney Gary S. | director, officer: President and CEO | Feb 15, 2026 | TAX W/H | 82,815 | $3.73 | $308.9K | Form 4 |
| Gillheeney Gary S. | director, officer: President and CEO | Feb 15, 2026 | TAX W/H | 85,605 | $3.73 | $319.3K | Form 4 |
| Grow Brian | Chief Commercial Officer | Feb 15, 2026 | TAX W/H | 3,346 | $3.73 | $12.5K | Form 4 |
| Grow Brian | Chief Commercial Officer | Feb 15, 2026 | TAX W/H | 18,910 | $3.73 | $70.5K | Form 4 |
| Grow Brian | Chief Commercial Officer | Feb 15, 2026 | TAX W/H | 10,559 | $3.73 | $39.4K | Form 4 |
| Grow Brian | Chief Commercial Officer | Feb 15, 2026 | TAX W/H | 11,144 | $3.73 | $41.6K | Form 4 |
| Montecalvo Antonio S. | Vice President, Health Policy | Feb 15, 2026 | TAX W/H | 1,389 | $3.73 | $5.2K | Form 4 |
| Montecalvo Antonio S. | Vice President, Health Policy | Feb 15, 2026 | TAX W/H | 9,607 | $3.73 | $35.8K | Form 4 |
| Montecalvo Antonio S. | Vice President, Health Policy | Feb 15, 2026 | TAX W/H | 4,100 | $3.73 | $15.3K | Form 4 |
| Montecalvo Antonio S. | Vice President, Health Policy | Feb 15, 2026 | TAX W/H | 3,523 | $3.73 | $13.1K | Form 4 |
| NUSSDORF GLENN H | director | Dec 16, 2025 | SELL | 200,000 | $5.14 | $1.0M | Form 4 |
| NUSSDORF GLENN H | director, 10 percent owner: | Nov 24, 2025 | SELL | 100,000 | $5.34 | $534.0K | Form 4 |
| NUSSDORF GLENN H | director, 10 percent owner: | Nov 25, 2025 | SELL | 12,043 | $5.30 | $63.8K | Form 4 |
| NUSSDORF GLENN H | director, 10 percent owner: | Nov 26, 2025 | SELL | 187,957 | $5.29 | $994.3K | Form 4 |
| NUSSDORF GLENN H | director, 10 percent owner: | May 15, 2025 | BUY | 107,494 | $2.99 | $321.0K | Form 4 |
| NUSSDORF GLENN H | director, 10 percent owner: | Jun 9, 2025 | SELL | 4,156 | $3.50 | $14.5K | Form 4 |
| NUSSDORF GLENN H | director, 10 percent owner: | Jun 10, 2025 | SELL | 18,620 | $3.56 | $66.3K | Form 4 |
| NUSSDORF GLENN H | director, 10 percent owner: | May 14, 2025 | BUY | 251,001 | $3.09 | $775.0K | Form 4 |
| Grow Brian | Chief Commercial Officer | Aug 11, 2025 | OPTION EX. | 4,060 | $2.47 | $10.0K | Form 4 |
| Grow Brian | Chief Commercial Officer | Aug 11, 2025 | TAX W/H | 2,173 | $4.62 | $10.0K | Form 4 |
| Grow Brian | Chief Commercial Officer | Aug 11, 2025 | OPTION EX. | 4,060 | $2.47 | $10.0K | Form 4 |
| Cavorsi Robert | Vice President, Strategy | Jul 16, 2025 | TAX W/H | 360 | $4.46 | $1.6K | Form 4 |
| Freedman Lori | Chief Admin. and Legal Officer | Jun 6, 2025 | BUY | 9,022 | $2.99 | $26.9K | Form 4 |
| Freedman Lori | Chief Admin. and Legal Officer | Jun 5, 2025 | BUY | 142,379 | $2.91 | $413.6K | Form 4 |
| Freedman Lori | Chief Admin. and Legal Officer | Jun 4, 2025 | BUY | 100,863 | $2.82 | $284.7K | Form 4 |
| Cavorsi Robert | Vice President, Strategy | Mar 9, 2025 | TAX W/H | 210 | $5.16 | $1.1K | Form 4 |